What does LBR refer to in dermatology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

LBR in Dermatology

In dermatology, LBR refers to Lichen sclerosus (formerly called "Balanitis Xerotica Obliterans" in males), an inflammatory scarring dermatosis characterized by a lymphocytic response with predilection for genital skin in both sexes. 1

Definition and Terminology

  • LBR is an outdated acronym for "Lichen sclerosus et atrophicus" or specifically "Balanitis Xerotica Obliterans" when referring to penile lichen sclerosus; these terms should no longer be used. 1

  • The suffix "et atrophicus" has been dropped because some cases present with hypertrophic rather than atrophic epithelium. 1

  • The term "kraurosis vulvae" is similarly obsolete and refers to vulvar lichen sclerosus. 1

Clinical Presentation

Female Patients

  • Lichen sclerosus presents as porcelain-white papules and plaques affecting the interlabial sulci and labia minora, often with areas of ecchymosis. 1, 2

  • The disease has a bimodal age distribution with peaks in prepubertal girls and postmenopausal women. 1, 2

  • Scarring may lead to labial fusion or introitus narrowing if left untreated. 2

Male Patients

  • In males, lichen sclerosus typically affects the prepuce and glans, potentially causing phimosis and urethral stenosis. 1

  • The disease rarely occurs in boys circumcised at birth, suggesting that a moist environment under the foreskin predisposes to development. 1

  • Perianal involvement is extremely rare in males. 1

Diagnostic Approach

  • Biopsy is essential for definitive diagnosis, particularly when lesions are pigmented, indurated, fixed, ulcerated, or fail to respond to standard therapy. 3, 2

  • Classical histological features include thinned epidermis with hyperkeratosis, a wide band of homogenized collagen below the dermoepidermal junction, and a lymphocytic infiltrate beneath the homogenized area. 1

  • Screen for other autoimmune diseases, particularly thyroid disease in women, as lichen sclerosus has autoimmune associations. 1

Treatment Recommendations

First-Line Therapy

  • Clobetasol propionate 0.05% ointment applied once daily for 1-3 months is the first-line treatment for confirmed lichen sclerosus. 3, 2

  • Use emollients as soap substitutes and barrier preparations. 3

  • For male patients, treatment with topical clobetasol propionate 0.05% cream twice daily for 2-3 months is recommended. 3

Refractory Cases

  • Consider repeat 1-3 month courses of topical corticosteroids for relapses. 3

  • Intralesional triamcinolone (10-20 mg) may be used for steroid-resistant hyperkeratotic areas after biopsy excludes malignancy. 3

  • For male patients with urethral stricture who fail topical steroids and/or circumcision, refer to a urologist specialized in lichen sclerosus management for surgical options such as total or partial glans resurfacing and split-skin grafting. 1

Surgical Management

  • In males with lichen sclerosus limited to the glans and foreskin, circumcision alone is successful in 96% of cases. 3

  • All removed tissue from circumcision must be sent for histological examination to confirm lichen sclerosus and exclude penile intraepithelial neoplasia. 3

  • For female patients with fusion over the clitoris, optimal surgical management remains an area requiring further research. 1

Critical Pitfalls and Long-Term Management

  • Untreated genital lichen sclerosus carries an increased risk of progression to squamous cell carcinoma; long-term surveillance is therefore mandatory. 3, 2

  • Even asymptomatic lichen sclerosus should be treated to prevent disease progression and potential malignancy. 2

  • In children, phimosis may actually represent undiagnosed lichen sclerosus, as this condition is underrecognized in pediatrics. 3

  • Avoid potent topical steroids in children due to risks of cutaneous atrophy, adrenal suppression, and hypopigmentation. 3

  • Do not confuse lichen sclerosus with other white plaque conditions such as lichen planus, as there can be an overlap syndrome with hyperkeratosis and poor response to ultrapotent topical corticosteroids. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnosis of Papule on Labia Minora

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment and Management of Balanitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.